London & the life sciences

Europe’s biotech industry is more buoyant now than it’s ever been. 

A combination of eager investors, the high-speed development of COVID-19 vaccines, exciting scientific developments and last year’s acceleration of existing trends is driving the sector to new heights. And as part of one of the world’s largest life science technology clusters in the so-called Golden Triangle with Oxford and Cambridge, London is riding that wave.

Latest insights

More Insights
Curiosity line teal background

A Clearly Drafted Discretionary Bonus Clause Upholds Employer’s Right to Withhold Bonuses

Sep 20 2024

Read More

EU – DAC6 - ECJ further clarifies the mandatory disclosure obligation

Sep 20 2024

Read More
Folder

Investing in data centres: understanding Permanent Establishment issues

Sep 19 2024

Read More